Pembrolizumab in Biliary Tract Cancer

Clinical trial NCT03260712 · COMPLETED

Trial details

NCT number: NCT03260712
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Biliary Tract Cancer Metastatic Cancer Advanced Cancer Gallbladder Cancer

Start date: 2020-01-07
Primary completion: 2023-04-27
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.